These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28392281)

  • 1. Human stem cell modeling in neurofibromatosis type 1 (NF1).
    Wegscheid ML; Anastasaki C; Gutmann DH
    Exp Neurol; 2018 Jan; 299(Pt B):270-280. PubMed ID: 28392281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.
    Monroe CL; Dahiya S; Gutmann DH
    Annu Rev Pathol; 2017 Jan; 12():53-74. PubMed ID: 28135565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.
    Toonen JA; Anastasaki C; Smithson LJ; Gianino SM; Li K; Kesterson RA; Gutmann DH
    Hum Mol Genet; 2016 May; 25(9):1703-13. PubMed ID: 26908603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME; Gutmann DH
    J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
    Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
    Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1.
    Cimino PJ; Gutmann DH
    Handb Clin Neurol; 2018; 148():799-811. PubMed ID: 29478615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
    Bajenaru ML; Hernandez MR; Perry A; Zhu Y; Parada LF; Garbow JR; Gutmann DH
    Cancer Res; 2003 Dec; 63(24):8573-7. PubMed ID: 14695164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromin in the brain.
    Gutmann DH
    J Child Neurol; 2002 Aug; 17(8):592-601; discussion 602-4, 646-51. PubMed ID: 12403558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic Pathway Gliomas in Neurofibromatosis Type 1.
    Campen CJ; Gutmann DH
    J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of tumor development in neurofibromatosis type 1.
    Cichowski K; Shih TS; Schmitt E; Santiago S; Reilly K; McLaughlin ME; Bronson RT; Jacks T
    Science; 1999 Dec; 286(5447):2172-6. PubMed ID: 10591652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological malignancies in neurofibromatosis type 1.
    Eoli M; Saletti V; Finocchiaro G
    Curr Opin Oncol; 2019 Nov; 31(6):554-561. PubMed ID: 31436563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1:
    Tritto V; Ferrari L; Esposito S; Zuccotti P; Bianchessi D; Natacci F; Saletti V; Eoli M; Riva P
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31694342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in neurofibromatosis type 1.
    Arun D; Gutmann DH
    Curr Opin Neurol; 2004 Apr; 17(2):101-5. PubMed ID: 15021234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF1 mutation drives neuronal activity-dependent initiation of optic glioma.
    Pan Y; Hysinger JD; Barron T; Schindler NF; Cobb O; Guo X; Yalçın B; Anastasaki C; Mulinyawe SB; Ponnuswami A; Scheaffer S; Ma Y; Chang KC; Xia X; Toonen JA; Lennon JJ; Gibson EM; Huguenard JR; Liau LM; Goldberg JL; Monje M; Gutmann DH
    Nature; 2021 Jun; 594(7862):277-282. PubMed ID: 34040258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of coexisting genetic mutations on murine optic glioma biology.
    Kaul A; Toonen JA; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 May; 17(5):670-7. PubMed ID: 25246427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of neurofibromatosis type 1.
    Korf BR
    Curr Neurol Neurosci Rep; 2001 Mar; 1(2):162-7. PubMed ID: 11898512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
    Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
    Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis 1.
    Lynch TM; Gutmann DH
    Neurol Clin; 2002 Aug; 20(3):841-65. PubMed ID: 12432832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.